Positron Emission Tomography (PET) Predictors of Tumor Response to Peptide Receptor Radionuclide Therapy (PRRT) in Metastatic Neuroendocrine Tumors (NET)

被引：0
|
作者：
Ladwa, R. [1 ]
Pattison, D. [2 ]
Smith, J. [2 ]
Goodman, S. [2 ]
Burge, M. [3 ]
Rose, S. [4 ]
Dowson, N. [4 ]
Wyld, D. [3 ]
机构：
[1] Univ Queensland, Sch Med, Princess Alexandra Hosp, Dept Med Oncol, Brisbane, Qld, Australia
[2] Royal Brisbane & Womens Hosp, Nucl Med & Specialised PET Serv, Brisbane, Qld, Australia
[3] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Canc Care Serv, Brisbane, Qld, Australia
[4] CSIRO Hlth & Biosecur, Australian E Hlth Res Ctr, Brisbane, Qld, Australia
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
68ga-dotatate pet-ct; suv parameters; tumor response; somatostatin receptor tumor volume;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K11
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [42] Pretherapeutic Predictors of Tumor Absorbed Dosimetry in Radionuclide Therapy for Metastatic Neuroendocrine Tumors
    Ladwa, R.
    Pattison, D.
    Smith, J.
    Goodman, S.
    Burg, M.
    Rose, S.
    Dowson, N.
    Wyld, D.
    NEUROENDOCRINOLOGY, 2018, 106 : 250 - 250
  • [43] Can tumor absorbed dose predict response to Peptide Receptor Radionuclide Therapy (PRRT) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)?
    Mileva, M.
    Marin, G.
    Levillain, H.
    van Bogaert, C.
    Critchi, G.
    Marin, C.
    Flamen, P.
    Karfis, I
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 153 - 153
  • [44] POSITRON EMISSION TOMOGRAPHY (PET) IN NEUROENDOCRINE GASTROINTESTINAL TUMORS
    ERIKSSON, B
    BERGSTROM, M
    LILJA, A
    AHLSTROM, H
    LANGSTROM, B
    OBERG, K
    ACTA ONCOLOGICA, 1993, 32 (02) : 189 - 196
  • [45] The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors
    Bodei, Lisa
    Cwikla, Jaroslaw B.
    Kidd, Mark
    Modlin, Irvin M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 : S1511 - S1523
  • [46] Favourable Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) for Treatment of Metastatic Rectal Neuroendocrine Neoplasia (NEN)
    Kong, G.
    Grozinsky-Glasberg, S.
    Akhurst, T.
    Hofman, M.
    Meirovitz, A.
    Maimon, O.
    Schwartz, A.
    Michael, M.
    Gross, D. J.
    Hicks, R.
    NEUROENDOCRINOLOGY, 2018, 106 : 247 - 247
  • [47] Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
    Kong, Grace
    Grozinsky-Glasberg, Simona
    Hofman, Michael S.
    Akhurst, Tim
    Meirovitz, Amichay
    Maimon, Ofra
    Krausz, Yodphat
    Godefroy, Jeremy
    Michael, Michael
    Gross, David J.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 718 - 727
  • [48] Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)
    Grace Kong
    Simona Grozinsky-Glasberg
    Michael S. Hofman
    Tim Akhurst
    Amichay Meirovitz
    Ofra Maimon
    Yodphat Krausz
    Jeremy Godefroy
    Michael Michael
    David J. Gross
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 718 - 727
  • [49] Hepatotoxicity From Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NETs) Patients With Very High Liver Tumor Burden
    Gococo-Benore, Denise A.
    Parent, Ephraim
    Sharma, Akash
    Accurso, Joseph
    Yang, Ming
    Kendi, Ayse Tuba
    Sonbol, Bassam
    Halfdanarson, Thorvardur R.
    Starr, Jason S.
    PANCREAS, 2022, 51 (03) : E47 - E47
  • [50] Peptide Receptor Radionuclide Therapy (PRRT) a Novel Option as Neoadjuvant Therapy for Pancreatic Neuroendocrine Tumors: A Surgical Series
    Miotto, M.
    Nessi, C.
    Cingarlini, S.
    Severi, S.
    Paganelli, G.
    Malleo, G.
    D'Onofrio, M.
    Pea, A.
    Vincenzi, S.
    Scarpa, A.
    Salvia, R.
    Landoni, L.
    NEUROENDOCRINOLOGY, 2019, 108 : 254 - 254
12345